Kopran Limited — Kit Exporter Profile
Indian Pharmaceutical Exporter · #14 for Kit · $2.6M export value · DGFT Verified
Kopran Limited is the #14 Indian exporter of Kit with $2.6M in export value and 124 verified shipments. Kopran Limited holds a 0.6% market share in Kit exports across 8 countries. The company exports 6 pharmaceutical products worth $7.3M across 5 therapeutic categories.
Kopran Limited — Kit Export Profile: Buyers & Destinations
Where Does Kopran Limited Export Kit?
| Country | Value | Shipments | Share |
|---|---|---|---|
| ETHIOPIA | $962.3K | 55 | 42.3% |
| THAILAND | $507.5K | 28 | 22.3% |
| SUDAN | $243.3K | 6 | 10.7% |
| MYANMAR | $205.5K | 8 | 9.0% |
| CAMBODIA | $139.3K | 6 | 6.1% |
| TANZANIA | $112.5K | 9 | 4.9% |
| KENYA | $87.1K | 6 | 3.8% |
| MOZAMBIQUE | $20.0K | 13 | 0.9% |
Kopran Limited exports Kit to 8 countries. The largest destination is ETHIOPIA accounting for 42.3% of Kopran Limited's Kit shipments, followed by THAILAND (22.3%) and SUDAN (10.7%). These destinations reflect Kopran Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Kit from Kopran Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF | THAILAND | $1.6M | 99 |
| CHEM-I-PLAST PTY LIMITED | ETHIOPIA | $174.7K | 7 |
| KASIKORNBANK PUBLIC COM PANYLIMITED BANGKOK | THAILAND | $133.0K | 6 |
| TO THE ORDER | SUDAN | $65.0K | 3 |
| COMMERCIAL BANK OF ETHIOPIA | ETHIOPIA | $50.0K | 1 |
| VE CAMBODIA LIMITEDNO | CAMBODIA | $42.4K | 1 |
| OROMIA INTERNATIONAL BANK | ETHIOPIA | $36.2K | 1 |
| AMHARA BANK | ETHIOPIA | $22.9K | 1 |
| COMMERCIAL BANK OF | ETHIOPIA | $22.8K | 1 |
| TO THE ORDER OF AWASH BANK S.C., | ETHIOPIA | $22.4K | 1 |
Kopran Limited supplies Kit to 17 buyers globally. The largest buyer is TO THE ORDER OF (THAILAND), followed by CHEM-I-PLAST PTY LIMITED (ETHIOPIA) and KASIKORNBANK PUBLIC COM PANYLIMITED BANGKOK (THAILAND). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Kit Export Value and How Much Does Kopran Limited Contribute?
India exported $57.8M worth of Kit through 15,000 shipments from 1048 suppliers to 191 countries, serving 3,293 buyers globally. Kopran Limited contributes $2.6M to this total, accounting for 0.6% of India's Kit exports. Kopran Limited ships Kit to 8 countries through 17 buyers.
What Is the Average Shipment Value for Kopran Limited's Kit Exports?
Kopran Limited's average Kit shipment value is $21.0K per consignment, based on 124 shipments totaling $2.6M. The largest destination is ETHIOPIA (42.3% of Kopran Limited's Kit exports).
How Does Kopran Limited Compare to Other Indian Kit Exporters?
Kopran Limited ranks #14 among 1048 Indian Kit exporters with a 0.6% market share. The top 3 exporters are SANDOZ PRIVATE LIMITED ($7.8M), MERIL DIAGNOSTICS PRIVATE LIMITED ($5.6M), MICRO LABS LIMITED ($5.5M). Kopran Limited processed 124 shipments to 8 destination countries.
What Kit Formulations Does Kopran Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| HARMLESS MEDICINE / PHARMACEUTICAL GOODSLOKIT 20MG CAPSULES (OMEPRAZOLE CAPSULES 20MG) | $560.4K | 28 |
| HARMLESS MEDICINE / PHARMACEUTICAL GOODSLOKIT 20MG CAPSULES OMEPRAZOLE CAPSULES 20MG | $473.1K | 17 |
| HARMLESS MEDICINE / PHARMACEUTICAL GOODSLOKIT 20MG CAPSULES (OMEPRAZOLE CAPSULES 20MG) (EACH CAPSULE CONTAINS OMEPRAZOL | $118.8K | 8 |
| HARMLESS MEDICINE / PHARMACEUTICAL GOODSLOKIT 20MG CAPSULES (OMEPRAZOLE CAPSULES 20MG)NOS | $75.6K | 8 |
| HARMLESS MEDICINE PHARMACEUTICAL GOODSLOKIT HP COMBIPACK OF CLARITHROMYCIN250MG TABLETS OMEPRAZOLE 20MG CAPSULES | $50.0K | 1 |
| HARMLESS MEDICINE / PHARMACEUTICAL GOODSLOKIT 20MG CAPSULES 71795 PACKS OF 10X10 CAPS EACH (OMEPRAZOLE CAPSULES 20MG) ( | $50.0K | 1 |
| HARMLESS MEDICINE / PHARMACEUTICAL GOODSLOKIT 20MG CAPSULES (OMEPRAZOLE CAPSULES 20MG) 65451 PACKS OF 10X10 CAPS EACH ( | $50.0K | 1 |
| HARMLESS MEDICINE/PHARMACEUTICAL GOODS LOKIT 20MG CAPSULES 432820 JARS OF 14 CAPS EACH (OMEPRAZOLE CAPSULES 20MG) (EACH | $50.0K | 1 |
| HARMLESS MEDICINE / PHARMACEUTICAL GOODSLOKIT 20MG CAPSULES (OMEPRAZOLE CAPSULES 20MG) 65425 PACKS OF 10X10 CAPS EACH ( | $50.0K | 1 |
| HARMLESS MEDICINE/PHARMACEUTICAL GOODS LOKIT HP CAPSULES 76428 PACKS OF 7X6 CAPSEACH (COMBIPACK OF CLARITHROMYCIN 250MG | $50.0K | 1 |
Kopran Limited exports 60 distinct Kit formulations including tablets, capsules, syrups, and combination drugs. The top formulation is HARMLESS MEDICINE / PHARMACEUTICAL GOODSLOKIT 20MG CAPSULES with 28 shipments worth $560.4K.
How Does Kopran Limited Compare to Nearest Kit Exporters?
Exporters ranked immediately above and below #14 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 13 | ARKRAY HEALTHCARE PRIVATE LIMITED | $3.1M | 655 | 55 | $4.8K |
| 3 | RELIANCE LIFE SCIENCES PRIVATE LIMITED | $2.7M | 54 | 16 | $50.0K |
| 14 | KOPRAN LIMITED ★ | $2.6M | 124 | 8 | $21.0K |
| 2 | PAR FORMULATIONS PRIVATE LIMITED | $2.5M | 49 | 1 | $50.0K |
| 12 | BABA AGENCIES | $2.5M | 49 | 1 | $50.0K |
Kopran Limited ranks #14 among 1048 Indian Kit exporters. Average shipment value of $21.0K compared to the market average of $55.1K. The closest competitors by value are ARKRAY HEALTHCARE PRIVATE LIMITED and RELIANCE LIFE SCIENCES PRIVATE LIMITED.
Which Indian Ports Ship Kit Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 2,763 | 18.4% |
| SAHAR AIR | 2,534 | 16.9% |
| DELHI AIR CARGO ACC (INDEL4) | 1,051 | 7.0% |
| DELHI AIR | 983 | 6.6% |
| NHAVA SHEVA SEA (INNSA1) | 901 | 6.0% |
| Bombay Air | 541 | 3.6% |
| JNPT/ NHAVA SHEVA SEA | 433 | 2.9% |
| CHENNAI AIR CARGO ACC (INMAA4) | 405 | 2.7% |
About Kopran Limited
Kopran Limited exports 6 products worth $7.3M. Beyond Kit, top products include Enalapril, Flucloxacillin, Clarithromycin, Atenolol, Salmeterol. View the complete Kopran Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Kit — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Kit shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Kopran Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 131 individual customs records matching Kopran Limited exporting Kit, covering 60 formulations to 8 countries via 17 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 191+ countries, 3,293+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Kit Export Data from Kopran Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Kopran Limited's Kit exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Kopran Limited
Full Company Profile →
6 products · $7.3M total trade · 5 categories
Kit Stats
Company Overview
Top Products by Kopran Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Kopran Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Kit. For current shipment-level data, contact TransData Nexus.